Functional status and mortality in chronic kidney disease: Results from a prospective observational study

Nephron - Clinical Practice

Volumn 128, Issue 1-2, 2014, Pages 22-28

  Ritchie, James P ^a   Alderson, Helen ^a   Green, Darren ^a   Chiu, Diana ^a   Sinha, Smeeta ^a   Middleton, Rachel ^a   O'Donoghue, Donal ^a   Kalra, Philip A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Chronic kidney disease; Functional status; Mortality; Progression

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; FEMALE; FUNCTIONAL STATUS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RENAL REPLACEMENT THERAPY; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84927587990     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000362453     Document Type: Article

References (27)

1. Tonelli M: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17:2034-2047.
2. Cruz MC, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, Sesso Rde CC: Quality of life in patients with chronic kidney disease. Clinics 2011; 66:991-995.
3. Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu C-Y, Bindman AB, et al: Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 2005; 68:2801-2808.
4. Kellerman QD, Christensen AJ, Baldwin AS, Lawton WJ: Association between depressive symptoms and mortality risk in chronic kidney disease. Health Psychol 2010; 29:594-600.
5. Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH: Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology (Carlton) 2009; 14:240-246.
6. Johansen KL, Kaysen GA, Dalrymple LS, Grimes BA, Glidden DV, Anand S, et al: Association of physical activity with survival among ambulatory patients on dialysis: the Comprehensive Dialysis Study. Clin J Am Soc Nephrol 2013; 8:248-253.
7. Hoefield RA, Kalra PA, Baker P, Lane B, New JP, O'Donoghue DJ, et al: Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis 2010; 56:1072-1081.
8. Goddard J, Harris K, Turner N: UK Renal Association eCKD guide. http://www.renal.org.
9. British Cardiac Society, British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association: JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(suppl 5):v1-v52.
10. Karnofsky DA, Burchenal JH: The Clinical Evaluation of Chemotherapeutic Agents in Cancer. Evaluation of Chemotherapeutic Agents. New York, Columbia University Press, 1949, pp 199-205.
11. Singer JD: Applied Longitudinal Data Analysis, ed 1st. Oxford, Oxford University Press, 2003, pp 75-132.
12. Diggle PJ, Heagerty P, Liang KY: Analysis of Longitudinal Data, ed 2nd. Oxford, Oxford University Press, 2002, pp 54-80.
13. Kimmel PL, Patel SS: Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol 2006; 26:68-79.
14. Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA: The predictive value of self-report scales compared with physician diagnosis of depression in hemodi-alysis patients. Kidney Int 2006; 69: 1662-1668.
15. Little MA, Nazar L, Farrington K: Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity. Nephrol Dial Transplant 2004; 19:356-364.
16. Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16(suppl 1):S83-S88.
17. Perkins RM, Bucaloiu ID, Kirchner HL, Ashouian N, Hartle JE, Yahya T: GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:1879-1886.
18. Babazono T, Hanai K, Suzuki K, Kiuchi Y, Inoue A, Tanaka M, et al: Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia 2006; 49: 1387-1393.
19. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al: Progression of kidney dysfunction in the community-dwelling elderly. Kidney International 2006; 69: 2155-2161.
20. Schneider A, Jardine AG, Schneider MP, Hold-aas H, Holme I, Fellstroem BC, et al: Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study. Am J Nephrol 2013; 37:144-151.
21. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lip-kowitz MS, et al: Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 2012; 59:504-512.
22. O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al: Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis 2012; 59:513-522.
23. Rucci P, Mandreoli M, Gilbertoni D, Zuccala A, Fantini MP, Lenzi J, et al: A clinical stratification tool for chronic kidney disease progression rate based on a classification tree analysis. Nephrol Dial Transplant 2013, DOI: 10.1093/ndt/gft444, Epub ahead of print.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
25. Cruz RJ, Dew MA, Myaskovsky L, Goodpas-ter B, Fox K, Fontes P, et al: Objective radio-logic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation 2013; 95: 617-622.
26. Shastri S, Sarnak MJ: Chronic kidney disease: high eGFR and mortality: high true GFR or a marker of frailty? Nat Rev Nephrol 2011; 7: 680-682.
27. Liem BJ, Holland JM, Kang MY, Hoffelt SC, Marquez CM: Karnofsky Performance Status Assessment: resident versus attending. J Cancer Educ 2002; 17:138-141.